Fig. 2From: FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cellsThe comparison for expression of FOLR1 with different clinicopathological factors.#,P = 0.047,mucinous vs serous;▲,P = 0.013,G1 vs G2-G3;*,P = 0.013,stage I-II vs stage III-IVBack to article page